When is the deadline for Salisbury Award for Entrepreneurial Translational Research?

This grant has a rolling deadline or the deadline has not been announced.

Salisbury Award for Entrepreneurial Translational Research

Q: How much funding does Salisbury Award for Entrepreneurial Translational Research provide?

Salisbury Award for Entrepreneurial Translational Research provides $3,000 (winner), $1,500 (runner-up) in funding.

National Foundation For Cancer Research

Foundation Annual Grants for Cancer Nonprofits Grants for Science Research

Apply Now

Funding Amount

$3,000 (winner), $1,500 (runner-up)

Deadline

Rolling / Open

Grant Type

foundation

Overview

Salisbury Award for Entrepreneurial Translational Research

Funder: National Foundation for Cancer Research (NFCR)

Purpose: The Salisbury Award encourages and promotes innovative scientists and early-stage start-up companies to translate their discoveries into therapies that can improve the lives of cancer patients. It is designed to identify 'high risk, high impact and high reward' projects and help accelerate the pace for them to get into clinics faster.

Award Criteria:

Granted to faculty or non-faculty investigators within world-class institutions

Early-stage cancer therapeutic, diagnostic or vaccine projects

Evaluation based on best combination of: novel, feasible, impactful and patentable technology with clear clinical trial pathway

Focus Areas:

Cancer therapeutics (including CAR-T cell therapies, solid tumors)

Cancer diagnostics

Cancer vaccines

Translational research bridging laboratory discovery to clinical application

Award Benefits:

Cash prize (winner: $3,000; runner-up: $1,500; honorable mention recognized)

Introduction to NFCR fellows, scientific advisory board members and other affiliates

Opportunity to participate in NFCR's biennial research symposia

Future eligibility to compete for multiyear Recoverable Translational Research Grants (up to $250,000 for associated start-up firms in Salisbury Venture Competition)

Eligibility:

Faculty and non-faculty investigators at world-class research institutions

Early-stage projects with clear path to human clinical trials

Geographic Scope: International (competitions held in cooperation with major research institutes)

Background: Established in 2019, named in honor of the Salisbury family (Franklin Sr., Tamara, and Franklin Jr.) whose 80+ years of service helped galvanize NFCR into a significant force for cancer research worldwide.

Contact:

Bradley Gillenwater, Senior Director Global Program Development

Email: bgillenwater@nfcr.org

Phone: 301-961-9161

Address: 5515 Security Lane, Suite 1105, Rockville, MD 20852

General: 1-800-321-CURE (2873) or info@nfcr.org

How to Apply

Application Process

Format:

Presentations pitched by participants vying for awards

Evaluated by panel of well-known professionals in cancer research community (academic, business, clinical)

Selection Criteria:

Novel, feasible, and impactful technology

Patentable intellectual property

Clear clinical trial pathway

Potential for translation to patient benefit

Judging Panel:

Includes key opinion leaders in cancer research

Business professionals from life sciences and venture investment sectors

Previous panelists include Harvard Medical School faculty, Ludwig Institute for Cancer Research, Scripps Research, former Avera Cancer Institute leadership, and venture capital firms

Note: Specific application deadlines and detailed submission requirements not provided in available materials. Contact NFCR directly for current application timeline and procedures.

Apply with Grantable Learn more